Anesthetic departments played a critical role in Australia’s COVID-19 response by facilitating the collection of residual blood samples from children undergoing elective procedures. Through a partnership with the Pediatric Active Enhanced Disease Surveillance network, this approach enabled three national SARS-CoV-2 serosurveys between 2020 and 2023. It provided an ethical, feasible, and nationally representative method for assessing infection- and vaccine-derived immunity in children, a population in whom routine blood sampling is difficult and from whom residual blood samples are not commonly available. The resulting data informed COVID-19 vaccination policy, improved understanding of infection burden and immunity, and contributed to broader public health decision-making. This experience demonstrates how anesthetic departments can extend their impact beyond perioperative care, serving as essential partners in public health surveillance and research.
No takes yet. Share an insight, caveat, or question.
Koirala et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: